Regeneron Drugs Show Favorable Signs in Trials

Regeneron Pharmaceuticals’ experimental drugs to cut cholesterol and treat osteoarthritis showed strong signs of effectiveness in early-stage trials, the biotechnology company said on Wednesday.
CNBC